EMC Capital Management Sells 28,279 Shares of Ingevity Co. (NYSE:NGVT)

EMC Capital Management decreased its holdings in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 85.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,814 shares of the company's stock after selling 28,279 shares during the quarter. EMC Capital Management's holdings in Ingevity were worth $196,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. First Horizon Advisors Inc. increased its stake in shares of Ingevity by 45.9% in the third quarter. First Horizon Advisors Inc. now owns 862 shares of the company's stock valued at $34,000 after buying an additional 271 shares during the period. KBC Group NV increased its stake in shares of Ingevity by 50.8% in the third quarter. KBC Group NV now owns 1,574 shares of the company's stock valued at $61,000 after buying an additional 530 shares during the period. Blue Trust Inc. increased its stake in shares of Ingevity by 179.6% in the third quarter. Blue Trust Inc. now owns 2,505 shares of the company's stock valued at $98,000 after buying an additional 1,609 shares during the period. nVerses Capital LLC acquired a new position in shares of Ingevity in the third quarter valued at approximately $113,000. Finally, Nisa Investment Advisors LLC increased its stake in shares of Ingevity by 27.3% in the third quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company's stock valued at $151,000 after buying an additional 831 shares during the period. Institutional investors and hedge funds own 91.59% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, BMO Capital Markets increased their target price on shares of Ingevity from $40.00 to $47.00 and gave the company a "market perform" rating in a research report on Thursday, October 31st. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $52.17.

Ingevity Trading Up 2.6 %

NYSE:NGVT traded up $1.15 on Tuesday, reaching $44.73. 72,841 shares of the stock traded hands, compared to its average volume of 198,204. The firm has a market capitalization of $1.63 billion, a price-to-earnings ratio of -2.88 and a beta of 1.64. Ingevity Co. has a 1-year low of $30.90 and a 1-year high of $56.29. The company's 50 day moving average is $43.96 and its 200-day moving average is $40.95. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 6.52.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.